A Phase 1, Randomized, Open-label, Single-dose, 6-period Study To Investigate The Effect Of In Vitro Dissolution Rate On The In Vivo Bioavailability Of Extended Release Formulations Of Pregabalin In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia; Postherpetic neuralgia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 05 Jul 2016 Status changed from recruiting to completed.
- 13 Jun 2016 Planned primary completion date changed from 1 May 2016 to 1 Jun 2016.
- 26 May 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016.